Error: Could not add to watchlist. X

Trevena Inc

+ Watchlist
TRVN:US
NASDAQ GS
6.97
USD
0.06
0.87%
As of 20:10:00 ET on 06/02/2015.
Open
6.91
Day Range
6.80 - 7.10
Volume
226,700
Previous Close
6.91
52Wk Range
3.80 - 8.16
1 Yr Return
55.58%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.80
Market Cap (m USD)
274.314
Shares Outstanding (m)
39.356
Price/Sales (TTM)
437.73
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech
Profile
Trevena, Inc. develops pharmaceutical products. The Company offers discovery and development of agents targeting G-protein coupled receptors and therapies and drugs that treat acute heart failure, acute chronic pain, and depression. Trevena serves customers throughout the United States.
ADDRESS
1018 West 8th Avenue
Suite A
King Of Prussia, PA 19406
United States
PHONE
1-610-354-8840
  • Maxine Gowen
    President/CEO/Founder
  • Roberto Cuca
    Senior VP/CFO/Treasurer
  • John M Limongelli
    Senior VP/Secretary/Gen Cnsl
  • Michael W Lark
    Senior VP:Research
  • David Soergel
    Senior VP:Clinical Development
Show More